Classification of drug-resistant tuberculosis in an epidemic area

Lancet

Volumn 356, Issue 9223, 2000, Pages 22-25

  Van Rie, Annelies ^a,b   Warren, Robin ^a   Richardson, Madalene ^a   Gie, Robert P ^a   Enarson, Donald A ^c   Beyers, Nulda ^a   Van Helden, Paul D ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ARTICLE; DRUG RESISTANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SOUTH AFRICA; TUBERCULOSIS; CHILD; CLASSIFICATION; CLUSTER ANALYSIS; COMPARATIVE STUDY; DISEASE TRANSMISSION; EPIDEMIC; GENETICS; INCIDENCE; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDY; SERODIAGNOSIS;

ADOLESCENT; ADULT; CHILD; CLUSTER ANALYSIS; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE; FEMALE; HIV SERONEGATIVITY; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSPECTIVE STUDIES; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0034218434     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(00)02429-6     Document Type: Article

References (19)

1. Pabloz Mendez A, Laszlo A, Bustreo F, et al. Anti-tuberculosis drug resistance in the world: the WHO/IUATLD global project on antituberculosis drug resistance surveillance 1994-1997. WHO/TB/97.229.
2. World Health Organization. WHO Report on the Tuberculosis Epidemic. Geneva: WHO, 1997.
3. Carpels G, Fissette K, Limbana V, et al. Drug resistant tuberculosis in Sub-Saharan Africa: an estimation of incidence and cost for the year 2000. Tuber Lung Dis 1995; 76: 480-86.
4. Crofton J, Chaulet P, Mahler D. Guidelines for the management of drug resistant tuberculosis. WHO/TB/96.21 (Rev/1) p8.
5. WHO/IUATLD Global Working Group on Antituberculosis Drug Resistance Surveillance. Guidelines for surveillance of drug resistance in tuberculosis. WHO Geneva / IUATLD Paris. Int J Tuber Lung Dis 1998; 2: 72-89.
6. Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD global surveillance project. Clin Infect Dis 1997; 24 (suppl 1): S121-30.
7. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco: a population based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703-09.
8. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiological methods. N Engl J Med 1994; 330: 1710-16.
9. Coronado VG, Beck-Sague CM, Hutton MD, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiological and restriction fragment length polymorphism analysis. J Infect Dis 1993; 168: 1052-55.
10. Frieden TR, Sherman LF, Maw KL, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcome. JAMA 1996; 276: 1229-35.
11. Valway SE, Richards SB, Kovacovich J, et al. Outbreak of multidrug-resistant tuberculosis in a New York State Prison, 1991. Am J Epidemiol 1994; 140: 113-22.
12. Fang Z, Doig C, Rayner A, et al. Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997). J Clin Microbiol 1999; 37: 998-1003.
13. Van Rie A, Warren R, Richardson M, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999; 341: 1174-79.
14. Weyer K, Groenewald P, Zwarenstein M, Lombard CJ. Tuberculosis drug resistance in the Western Cape. S Afr Med J 1995; 85: 499-504.
15. Van Embden JDA, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-09.
16. Warren R, Richardson M, Van Der Spuy G, et al. DNA fingerprinting and molecular epidemiology of tuberculosis: use and interpretation in an epidemic setting. Electrophoresis 1999; 20: 1807-12.
17. Hermans PWM, van Soolingen D, de Haas PEW, et al. Insertion element IS987 from Mycobacterium bovis BCG is located in a hotspot integration region for insertion elements in Mycobacterium tuberculosis complex strains. Infect Immun 1991; 59: 2695-705.
18. Warren R, Richardson M, Sampson S, et al. Genotyping of Mycobacterium tuberculosis with additional markers enhances accuracy in epidemiological studies. J Clin Microbiol 1996; 34: 2219-24.
19. Chaulet P, Boulahbal F, Grosset J. Surveillance of drug resistance for tuberculosis control: why and how? Tuber Lung Dis 1995; 76: 487-92.